Director, Global HEOR & Payer Access

Ipsen; England; Híbrido; GBP 90.000 - 140.000; Jornada completa

Descripción de la vacante

Ipsen is seeking a Director Global HEOR to lead value evidence generation across Oncology, Rare Disease and Neuroscience in a global setting. The role collaborates with Market Access, Medical Affairs, Regulatory and Clinical Development to deliver strategic HEOR outputs for early development, launch and mature phases.

The initial focus will be Rare Disease, with opportunities to work across Ipsen portfolio.

Formación

• Postgraduate degree in health economics or related quantitative discipline.
• 8+ years in HEOR within pharma, consultancy or academia, internationally.
• Experience with international HTA submissions.
• Strong scientific analysis, interpretation and writing skills.
• Knowledge of international health care systems and oncology/rare disease/neuroscience HEOR.

Responsabilidades

• Lead HEOR deliverables such as literature reviews and burden of illness studies.
• Plan and execute EU HTA regulatory activities aligned with product assignments.
• Support payer value evidence communication via abstracts and manuscripts.
• Develop cross-functional Integrated Evidence Generation Plans.
• Lead RWE and PROs strategy to support value propositions.
• Inform pipeline target product value profiles and payer endpoints.
• Support pricing policy and market access strategies.
• Collaborate with global and local cross-functional teams.
• Stay updated on payer and HTA landscape.

Conocimientos

HEOR strategy

Quantitative analysis

Evidence synthesis

Cost-effectiveness modeling

Budget impact modeling

RWE / PROs

HTA submissions

Scientific writing

Cross-functional collaboration

Educación

Postgraduate degree in health economics or related quantitative discipline

Descripción del empleo

Ipsen is seeking a Director Global HEOR to lead value evidence generation across Oncology, Rare Disease and Neuroscience in a global setting. The role collaborates with Market Access, Medical Affairs, Regulatory and Clinical Development to deliver strategic HEOR outputs for early development, launch and mature phases.

The initial focus will be Rare Disease, with opportunities to work across Ipsen portfolio.